Intellia Therapeutics, Inc. - NTLA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 06, 2026 | VP, Chief Accounting Officer | S | D | 2,641.0 | 16.78 | 44,315.98 | 66,886.0 | View | |
| Jul 06, 2026 | EVP, Chief Financial Officer | S | D | 4,677.0 | 18.0 | 84,186.0 | 156,286.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 35,148.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 41,083.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 33,559.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 32,609.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 216,653.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 143,893.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 36,403.0 | View | |
| Mar 03, 2026 | EVP, Chief Technical Officer | A | A | 10,505.0 | 0.0 | 0.0 | 10,505.0 | View | |
| Mar 03, 2026 | EVP, Chief Technical Officer | S | D | 607.0 | 13.78 | 8,364.46 | 93,864.0 | View | |
| Mar 03, 2026 | EVP, Chief Technical Officer | A | A | 7,353.0 | 0.0 | 0.0 | 94,471.0 | View | |
| Mar 03, 2026 | EVP, Chief Scientific Officer | A | A | 56,000.0 | 0.0 | 0.0 | 56,000.0 | View | |
| Mar 03, 2026 | EVP, Chief Scientific Officer | A | A | 39,200.0 | 0.0 | 0.0 | 137,733.0 | View | |
| Mar 03, 2026 | EVP, Chief Financial Officer | A | A | 87,543.0 | 0.0 | 0.0 | 87,543.0 | View | |
| Mar 03, 2026 | EVP, Chief Financial Officer | A | A | 61,280.0 | 0.0 | 0.0 | 160,963.0 | View | |
| Mar 03, 2026 | EVP, Chief Medical Officer | A | A | 14,204.0 | 0.0 | 0.0 | 14,204.0 | View | |
| Mar 03, 2026 | EVP, Chief Medical Officer | A | A | 9,943.0 | 0.0 | 0.0 | 131,192.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | A | A | 65,829.0 | 0.0 | 0.0 | 65,829.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | S | D | 1,211.0 | 13.78 | 16,687.58 | 156,794.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | A | A | 46,080.0 | 0.0 | 0.0 | 158,005.0 | View | |
| Mar 03, 2026 | President and CEO | A | A | 225,400.0 | 0.0 | 0.0 | 225,400.0 | View | |
| Mar 03, 2026 | President and CEO | A | A | 156,400.0 | 0.0 | 0.0 | 1,169,739.0 | View | |
| Mar 03, 2026 | VP, Chief Accounting Officer | A | A | 17,250.0 | 0.0 | 0.0 | 69,527.0 | View |